
Tylenol, pregnancy, and autism: What recent studies show and how to interpret the data
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this special episode of The Drive, Peter addresses the recent headlines linking acetaminophen (Tylenol) use during pregnancy to autism in exposed children. Recognizing the confusion these claims have sparked among patients, listeners, and the broader public, Peter uses this episode to provide a framework for thinking critically about complex conditions and the research related to them. He highlights the dramatic rise in autism diagnoses over recent decades, noting that multifactorial conditions rarely have a single cause, and emphasizes the importance of resisting oversimplified explanations. Peter also stresses that humans are not naturally wired for scientific thinking, making disciplined frameworks like the Bradford Hill criteria essential for evaluating causality in epidemiology. Ultimately, he uses this framework to explore the evidence surrounding acetaminophen use during pregnancy and its potential link to autism. We discuss: Laying the groundwork for this discussion, the rise in autism rates, and the value in using frameworks [1:00]; The FDA pregnancy drug categories, where Tylenol falls within that framework, and a structured method for evaluating scientific evidence and causality [6:00]; What exactly are the claims being made about acetaminophen and autism?
Publisher
The Peter Attia Drive
Link
peterattiamd.com/tylenolandautism/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=251006-pod-tylenolandautism&utm_content=251006-pod-tylenolandautism-podfeed
Published
October 6, 2025
Duration
1h 27m
Format
Podcast
Category
Lifestyle · Health & Wellness
Source
RSS feed
The Peter Attia Drive
@peterattiadrive
#pregnancy #recentstudies #interpret
